Department of Cardiology, University of Erlangen, Erlangen, Germany.
JACC Cardiovasc Imaging. 2010 Oct;3(10):1065-77. doi: 10.1016/j.jcmg.2010.08.010.
Imaging plays a central role in the diagnosis and management of coronary artery disease. Imaging is used for the detection of underlying coronary artery stenoses in patients with stable or chronic chest pain, for the assessment of myocardial scar and viability, for assessing prognosis, or for predicting complications. Echocardiography, nuclear imaging, cardiac magnetic resonance, and-more recently-computed tomography are powerful tools to provide answers to these questions. New technology, new contrast agents, and newly developed imaging protocols widen the applicability and increase accuracy of these imaging modalities, and new clinical studies provide information on their diagnostic potential and their therapeutic as well as prognostic value. The relative strengths and weaknesses of the different imaging modalities influence the selection of the most appropriate imaging approach in different clinical scenarios. This article outlines some of the most important developments of the past 12 months in the field of echocardiography, nuclear imaging, cardiac magnetic resonance, and computed tomography as they pertain to coronary artery disease.
影像学在冠心病的诊断和治疗中起着核心作用。影像学用于检测稳定或慢性胸痛患者的潜在冠状动脉狭窄，评估心肌瘢痕和活力，评估预后，或预测并发症。超声心动图、核成像、心脏磁共振成像，以及最近的计算机断层扫描，都是提供这些问题答案的有力工具。新技术、新对比剂和新开发的成像方案拓宽了这些成像方式的适用性并提高了其准确性，新的临床研究提供了关于其诊断潜力及其治疗和预后价值的信息。不同影像学方式的相对优势和劣势影响着在不同临床情况下选择最合适的影像学方法。本文概述了过去 12 个月中在超声心动图、核成像、心脏磁共振成像和计算机断层扫描领域与冠心病相关的一些最重要的进展。
